U.S. regulators have granted accelerated approval to the first in a new class of drugs for ovarian cancer, AstraZeneca PLC's Lynparza. … Click to Continue »
Living articles about food home & travel from in Kansas City, MO | KansasCity.com, Kansas City Star: Living
Fri, 12/19/2014 - 11:25am
U.S. regulators have granted accelerated approval to the first in a new class of drugs for ovarian cancer, AstraZeneca PLC's Lynparza. … Click to Continue »